US 11421010
T cells expressing membrane-anchored IL-12 for the treatment of cancer
granted A61KA61K2239/38A61K2239/50
Quick answer
US patent 11421010 (T cells expressing membrane-anchored IL-12 for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2239/38, A61K2239/50, A61K2239/55, A61K31/675